Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer

Journal: Cancer Research

Published: 2020-09-01

DOI: 10.1158/0008-5472.can-19-3934

Affiliations: 8

Authors: 30

Go to article
Institutions Share
St. Jude Children's Research Hospital (St. Jude), United States of America (USA) 0.97
Hartwell Center for Bioinformatics and Biotechnology, St. Jude, United States of America (USA) 0.03

Return